When M&A destroys value: what CFOs get wrong before the deal closes
Most M&A deals fail to deliver the returns promised at signing, and the damage is often locked in long before integration begins. CFOs who understand where value leaks occur can change the outcome.
In 2021, Microsoft acquired Nuance Communications for $19.7 billion. The strategic logic was clear, the synergies well-articulated, and the combined AI and healthcare positioningpositioningThe mental space you want your brand to occupy in your target customer's mind relative to alternatives.View full definition → genuinely compelling. Contrast that with the wave of SPAC-driven acquisitions from the same period: companies that rushed to market with minimal due diligence, inflated pro-forma projections, and governance structures that left CFOs little room to push back. By 2023 and into 2024, many of those deals had unwound spectacularly, wiping out billions in shareholder value. The difference between these two outcomes was not luck. It was the quality of financial thinking applied before the term sheet was signed.
The uncomfortable truth about M&A is that the average deal still destroys acquirer value. McKinsey research has consistently shown that roughly 70% of acquisitions fail to create the returns modeled at announcement. That number has not improved meaningfully over two decades, despite better data, more sophisticated valuation tools, and a growing library of post-mortem case studies. The failure is structural, not accidental.
Why value destruction is baked in early
The mechanics of how deals get done create systematic pressure toward overpayment. An investment bank advising on a deal earns its fee at close, not at the three-year post-integration mark. Management teams facing activist pressure or stagnant organic growth often pursue acquisitions to demonstrate strategic momentum. Boards, unless unusually rigorous, tend to approve deals that arrive with polished presentations and optimistic synergy cases. CFOs who push back risk being labeled obstructionist.
This creates a pattern that repeats across industries: synergy estimates are built top-down to justify a price already agreed in principle, due diligence focuses on confirming the thesis rather than stress-testing it, and integration costs are systematically underestimated. A 2022 study by Bain & Company found that acquirers routinely underestimate integration costs by 20 to 30%, and that revenue synergies, which typically account for 30 to 50% of the total synergy case, materialize at roughly half the rate of cost synergies.
The CFO occupies a structurally difficult position. Reporting to a CEO who is often the deal's internal champion, sitting across from bankers whose incentives run one way, and operating under confidentiality constraints that limit internal debate, it takes deliberate institutional design to create space for rigorous financial challenge.
What this means for the CFO
The CFO's most important contribution to any M&A process is not the valuation model itself. It is the governance architecture that surrounds it.
That starts with establishing a clean separation between the deal team and the synergy validation function. In large organizations, this means having a finance team that independently pressure-tests every line of the synergy case, with explicit authority to flag assumptions that cannot be substantiated. When Unilever pursued its failed attempt to acquire GlaxoSmithKline's consumer health division in early 2022, the public collapse of the deal revealed a governance failure: a synergy case that had not survived internal scrutiny, exposed only when the deal became public. The CFO who controls that internal scrutiny process protects the board and the shareholder base simultaneously.
Integration costs deserve specific attention. Most models include a line for "one-time integration charges," but the reality is that integration consumes management bandwidth, creates customer service disruption, and delays organic investment decisions for years. Amazon's $8.45 billion acquisition of MGM, also completed in 2022, required two years of regulatory review and a further 18 months of content and distribution integration before the strategic rationale became operationally visible. The cash opportunity cost of that delay rarely appears in the deal model.
On due diligence, the quality of financial information provided by sellers has improved significantly with the standardization of vendor due diligence reports, but CFOs should treat vendor-prepared materials with appropriate skepticism. A vendor due diligence report is commissioned by the seller. Its findings are useful as a starting point, not as a substitute for independent verification of working capitalworking capitalWorking capital is the difference between a company's current assets and current liabilities, measuring short-term liquidity and the funds available to run daily operations.View full definition → trends, customer concentration risk, and off-balance-sheet commitments.
There are two specific areas where deal models most frequently mislead. First, normalized EBITDAEBITDAEBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating profitability before financing and accounting decisions, used to compare core performance across firms.View full definition →: sellers routinely add back costs that are operationally recurring (management consulting fees, IT investments, litigation settlements that recur under different names). A disciplined CFO will insist on running a five-year EBITDA bridge, not just a trailing twelve months view. Second, tax structure: cross-border acquisitions in particular can carry embedded tax liabilities that are visible only with specialist review. The Pfizer-Allergan inversion deal, blocked in 2016 after US Treasury intervention, remains the canonical example of a deal where tax structuring assumptions were load-bearing and ultimately collapsed.
Practical positions worth holding
- Require the synergy model to be built bottom-up, with a named owner and delivery timeline for every line item, before any price is recommended to the board.
- Separate the integration cost estimate from the synergy case. They should live in different documents, with different owners, and reconcile only at the level of net present valuenet present valueNet Present Value is the sum of an investment's future cash flows discounted to today, minus the initial outlay. A positive NPV signals value creation.View full definition →.
- Build a "day one" and "day 100" operational checklist with the COO before signing, not after. The act of building it surfaces integration complexity that the deal model will otherwise paper over.
- When revenue synergies exceed 25% of the total synergy case, apply a 50% haircut as a baseline and explicitly show the board the deal returns at that reduced level.
- For any acquisition above a materiality threshold, commission an independent quality of earnings review from a firm with no other role in the transaction.
The CFO who insists on these disciplines will kill some deals. That is not a problem. The deals most worth killing are usually the ones where no one wants to hear the analysis.
M&A creates value when the price paid reflects realistic assumptions and integration is funded and managed as a multi-year operational program. CFOs who understand that their credibility is on the line at close, not just at signing, tend to make better decisions about which deals to champion and which to quietly walk away from.
Finished reading?
Validate your read to earn XP and feed your radar.